IDI Abstracts
- High willingness to use injectable antiretroviral therapy among women who have been lost to follow-up from HIV programmes: A nested cross-sectional study.
- Xpert MTB/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary.
2019
- Timing And Incidence Of Hiv-Associated Tuberculosis: A 4-Country Study” (Id 2379.
2018
- Call For Life Uganda Tm: An Rct Using Interactive Voice Response For Plhiv On Art” (Id 3031).
2018
- Double-Dose Levonorgestrel Implant Does Not Fully Overcome Interaction With Efavirenz” (Id 2726)
2018
- Subclinical Tubular Impairment Is Common In Art-Treated Hiv+ Patients In Uganda” (Id 2191).
2018
- Ugandan Clinic Experience Following Potential Teratogenicity Alert For Dolutegravir” (Id 2969).
2018
- Population Pk Of Dolutegravir In Plasma, Cord, And Breastmilk: Results From Dolphin-1″ (Id 2933).
2018
- The Impact Of HIV Exposure On Placental Pathology And Treg Cells” (Id 1916)
2018
- Presenting Conditions at an urgent care service within a specialist HIV Out patients Clinic in Uganda
2018
- The burden of chronic co-morbidities among HIV infected adults in a large Urban HIV Clinic In Uganda.
2018
- Etiology and Antimicrobial Resistance Patterns of Salmonella Bacteremia in Hospitalized Children with Acute Febrile Illness — Uganda, 2016–2017.
2018
- A pilot project to enhance research capacity building through in-house and peer mentorship
2018
- Advocates for patient safety in a large HIV outpatient facility: feasibility and impact of a pilot training program in Uganda
2018
- Causal relationship between risky sexual behavior and HIV testing among young adults (18-35 years) in Uganda: a structural equation analysis
2018
- Integrating Cervical Cancer Screening into routine HIV clinical care for women: A retrospective study of adherence to screening guidelines in an Urban HIV center in Uganda
2018
- Socioeconomic Indicators and Sexually Transmitted Infections Prevalence In Uganda: Using A Hierarchical Statistical Approach On A Nationally Representative Data
2018
- Socio-economic Disparities across Regions and their effect on risk of Sexually Transmitted Infections in Uganda
2018
- Long term risky sexual behavior among patients on antiretroviral therapy in urban and rural cohorts in Uganda: A longitudinal Prospective cohort study
2018
- Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda within the context of HIV test and treat: a cost-effectiveness modelling analysis
2018
- Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: a cost-effectiveness modeling analysis
2018
- DolPHIN-1 study group: Randomised controlled triak of dolutegravir (DTG)- Versus efavirenz(EFV) – based therapy in mothers initiating antiretroviral treatment in late pregnancy
2018
- Pharmacokinetics of efavirenz 400g when administered with Rifampicin and Isoniazid in HIV-TB co-infected patients in Uganda.
2018
- Sport betting Centers and Mobile Health Engagement: How to Find, Link and Retain Men for HIV prevention Or Treatment.
2018
- Paediatric Outcomes Among Infants Born To Hiv Positive Women Disengaged From A Pmtct Program In Uganda
2018
- Missed Clinic appointments and long term retention of HIV positive adults in care in a large HIV Clinic In Uganda.
2018
- High rates of lost to follow up during transition from youth friendly HIV clinics to Adult care in Urban Uganda
2018
- Residential Fertility Differences Among Women In Uganda: Application Of Non-Linear Oaxaca Blinder Decomposition
2018
- Correlates of Hepatic Fibrosis among HIV-Infected Individuals from an Urban Infectious Diseases Clinic In East Africa.
2018
- High rates of lost to follow up during transition from youth friendly HIV clinics to Adult care in Urban Uganda
2018
- Development and validation of an HPLC-UV multiplex assay for monitoring antiretroviral drugs in resource limited settings.
2018
- Compliance to guidelines for Routine Viral Load testing in resource limited settings
2018
- Missed Clinic appointments and long term retention of HIV positive adults in care in a large HIV Clinic In Uganda.
2018
- Socio-economic Disparities across Regions and their effect on risk of Sexually Transmitted Infections in Uganda
2018
- Causal relationship between risky sexual behavior and HIV testing among young adults (18-35 years) in Uganda: a Structural Equation Analysis
2018
- Integrating Cervical Cancer Screening into routine HIV clinical care for women: A retrospective study of adherence to screening guidelines in an Urban HIV center in Uganda
2018
- The burden of chronic co-morbidities among HIV-infected adults in a large Urban HIV clinic in Uganda
2018
- Virological Outcomes Among Young Adults At The Infectious Diseases Institute Kampala, Uganda
20018
- Long term risky sexual behavior among patients on antiretroviral therapy in urban and rural cohorts in Uganda: A longitudinal Prospective cohort study
2018
- Influence of Decision Making Process on Uptake Of Hiv Testing Among Women In Uganda
2018
- High risk of herbal medicine use in a cohort of HIV patients with comorbidities in a large urban HIV clinic in Uganda.
2018
- Medications safety issues associated with currently used First Line Anti-retroviral regimens in Uganda
2018
- Diagnostic utility of multiplex PCR in an HIV infected population with meningitis
2018
- Etiologies of symptomatic recurrence in HIV associated cryptococcal meningitis
2018
- High Mortality associated with unmasking cryptococcal meningitis
2018
- Differential brain tissue penetration of antiretrovirals and fluconazole.
2018
- Adjunctive sertraline in HIV-associated cryptococcal meningitis.
2018
- Customized amphotericin duration for cryptococcal meningitis based on fungal burden
2018
- Cyp2b6 Variants Alter Etonogestrel Pharmacokinetics When Combined With Efavirenz
2018
- Dolutegravir Interactions with Artemether-Lumefantrine and Amodiaquine-Artesunate
2018
- Compliance to Guidelines for Routine Viral Load Testing In Resource Limited Settings
2018
- Dolutegravir Vs Efavirenz When Initiating Treatment In Late Pregnancy.
2018
- Role of Chest X-Ray In The Diagnosis Of HIV-Associated Smear-Negative Tuberculosis In Uganda,
2018
- Improved Virological Outcomes In Co-Pay Hiv Clinic As A Model Of Differentiated Care.
2017
- Developing Media to promote Community Awareness of Early Detection of Kaposis Sarcoma In Africa.
2018
- Sustain Favourable TB Treatment Outcomes over 7 years of Integrated TB & HIV Services in a Large Urban Cohort in Uganda.
2018
- Reason for changing First line ART: the Role of toxicities over 12 years In a large urban program In Uganda
2018
- Poor Outcome Among Women who disengage from PMTCT services In Urban Uganda.
2017
- Capacity building of early career researchers using the Gilead Infectious Diseases training program at Infectious Diseases Institute: Achievements and challenges
2017
- , Exploring attitudes and perceptions of patients and staff towards “Call for life” system for HIV antiretroviral therapy in Uganda: A qualitative study.
2017
- Cardiovascular risk prediction in a cohort of HIV ART experienced patients in Uganda: A comparison of the DAD and WHO/ISH CVD risk score models.
2017
- Antibiotic use in Uganda Outpatients taking Current Antiretrovirals
2017
- Developing Media to promote Community Awareness of Early detection of Kaposi’s Sarcoma In Africa
2017
- Training Community Health workers about Early Detection Of Kaposi’s Sarcoma: A comparison of expert-led versus community health worker supervisor-led approaches.
2017
- Prevalence and Determinants of High Risks Human Papillomavirus mRNA Detected Through Community-based Cervical Cancer Screening In Uganda.
2017
- Prevention and Early Detection of Cervical Cancer In Africa through Community-Based Self – administered Screening and mobile treatment provision.
2017
- A Newly Esterblished Prospective Cohort in the ART Era Of Community Based Newly Diagnosed HIV Related Kaposi’ Sarcoma In Africa.
2017
- Feasibility of using Rapid Case Ascertainment to Evaluate Kaposi’ Sarcome In Africa
2017
- Portable Confocal Microscopy as a Diagnosis Tool for Kaposi Sarcoma In Africa.
2017
- Real world use of ART and Chemotherapy for Kaposi Sarcoma In A Large Community Based HIV Health care Network In Kenya.
2017
- Nucleic Acid Amplification Testing as a Means for Diagnosis of Kaposi Sarcoma In Africa
2017
- Feasibility of Using Rapid Case Ascertainment to Evaluate Kaposi Sarcoma in Africa
2017
- Timing Of Antiretroviral Therapy And Chemotherapy For Kaposi’s Sarcoma In A Large Community-Based Hiv Health Care Network In Kenya
2017
- Viral Hepatitis, Schistosomiasis as Risk Factors for Hepatocellular Carcinoma in Uganda.
2017
- Describing the use of long acting reversible contraceptive methods in a large urban HIV program in Uganda.
2017
- Advocates for patient safety in a large HIV outpatient facility: feasibility and impact of a pilot training program in Uganda
2017
- Innovating to improve health worker Continuous Professional Development (CPD): Challenges in evaluating utilisation of interactive online resources in Uganda
2017
- Risk factors for viral failure among HIV patients on antiretroviral therapy (ART) at the Infectious Diseases Institute Kampala Uganda
2017
- Risk factors for viral failure among HIV patients on antiretroviral therapy (ART) at the Infectious Diseases Institute Kampala Uganda
2017
- Prevalence, Factors and Preferred HIV-diagnosis Disclosure Methods among Adolescents living with HIV: A mixed methods study
2017
- 4. Describing the continuum of care in young adults who transition from adolescent to adult care
2917
- Efficacy of Option B-plus in a cohort of mother with high retention in averting paediatric transmission: low rates of transmission but high proportion of unreported outcomes,
2017
- Shadia et al Tolerability and satisfaction of levonorgestrel versus etonogestrel contraceptive implants among women living with HIV
2017
- Fungal Induce severe Asthma Among Ugandans
2017
- Towards More Accurate Determination of cancer Survival In Resource – Limited Settings: Tracking Patients with Kaposi Sarcoma Who are Lost To Follow-up In Sub-Saharan Africa
2017
- Cerebral Oximetry for Guiding Management in Cryptococcal Meningitis.
2017
- Reasons for LTFU and levels of HIV Sero-Status Disclosure among routine patients receiving care in urban Uganda
2017
- Feasibility of reporting the efficacy of Option B-plus in a Cohort of Mother with high retention in averting paediatric Transmission: Low rates of transmission but high proportion of unreported outcomes
2017
- Correction of estimates of retention for newly diagnosed HIV positive patients before the Initiation of ART In Uganda: A sample based approach
2017
- Describing the continuum of care in young adults who transition from adolescent to adult care
2017
- Efavirenz- but not nevirapine-based antiretroviral therapy significantly reduces etonogestrel concentrations in HIV+ women using subdermal contraceptive implants
2016
- High rates of multi-class drug resistance in HIV-1 infected individuals monitored with CD4 cell count in Uganda
2016
- Pharmacokinetic evaluation of efavirenz- and nevirapine-based antiretroviral therapy plus etonogestrel contraceptive implants
2016
- Low rifampicin and isoniazid concentrations are associated with delayed sputum conversion in HIV-positive patients co-infected with tuberculosis in Uganda
2016
- Improved adherence to antiretroviral treatment observed among children whose caregivers had positive beliefs in Medicine.
2016
- . Impact of Religiosity on HIV/AIDS Patient Retention in Care and Art Adherence in Uganda: A case study of the Infectious Diseases Institute Kampala Uganda
2016
- Implementation of routine viral load monitoring in a large urban clinic in Uganda
2016
- High rates of loss to follow-up among women on option B+ program attending care in urban Uganda.
2016
- Describing point of entry into care and lost to program in a cohort of HIV positive pregnant women in a large urban center in Uganda.
2016
- Virological Outcomes of Patients on Second line ART (boosted atazanavir versus boosted lopinavir)
2016
- Task sharing: Evaluation of intensive clinical mentorship on mid-level practitioners’ management of TB and HIV
2016
- Detrimental Outcomes Of Unmasking Cryptococcal Meningitis With Recent Art Initiation
2016
- PD-1 Expression on Peripheral Blood Plasma Blasts and Plasma Cells B Cells at Baseline is Associated with Survival in HIV-1 Infected ART-Naïve Cryptococcal Meningitis
2016
- Defective’ Cd4+ Cells And Susceptibility To Cryptococcal Meningitis In Individuals With Cd4 Count ≥100.
2016
- Predicting Sterility From Baseline Quantitative Fungal Culture; A Role For Customizing Therapy In Cryptococcal Meningitis?
2016
- Rapid Detection of CSF Sterility with Trypan Blue Using a Haemocytometer and TC20 Automated Counter Among HIV Patients with Cryptococcal Meningitis
2016
- Cryptococcus Neoformans Titan Cells fool the host Immune system
2016
- Oral PrEP enhances genital HIV-neutralizing IgAIn HIV -1 exposed seronegative (HESN) women
2016
- Short Message Service (SMS) Survey Assesing Pre-Exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable among HIV-Uninfected Members of Serodiscordant Couples In East Africa.
2016
- Responsible PrEP use: A qualitative Analysis of PrEP Adherence In Ugandan HIV Uninfected Partners In Serodiscordant Relationship.
2016
- . “It Was Easy”: A qualitative Analysis of Participants’ Experience Responding to Short Messages Service (SMS) surveys on Pre-Exposure Prophylaxis
2016
- Prevention-Effective Adherence per Short Message Service (SMS) within a demonstration Project of Pre-Exposure Prophylaxis (PrEP) Among HIV-Serodiscordant Couples In East Africa.
2016
- Prevention-Effective Adherence In Demonstration Project of Pre-exposure Prophylaxis (PrEP) Among HIV SerodiscordantCouples In East Africa
2016
- Describing point of entry into care and lost to program in a cohort of HIV positive pregnant women in a large urban center in Uganda
2016
- High rates of loss to follow-up among women on option B+ program attending care in urban Uganda
2016
- PK of FTC, TFV and 3TC in Ugandan and Nigerian Breastfeeding Mother-Infant Pairs
2016
- Transcriptomic Signature of Atorvastatin Response Among ART-Treated Adult In Africa
2016
- Atorvastatin Reduced T-Cell Activation and Exhaustion among Suboptimal Immune Responders: A Randomized Crossover Placebo Controlled Trial
2016
- Pre-ART Cryptococcal Antigen Titer is Associated with Failure of Preemptive Fluconazole Therapy.
2016
- Neurocognitive Function in HIV-Infected Persons With Cryptococcal Antigenemia
2016
- Immunologic Discrimination of Cryptococcal IRIS from Culture-Positive Relapse
2016
- Responsible PrEP use: A qualitative Analysis of PrEP Adherence In Ugandan HIV Uninfected Partners In Serodiscordant Relationship.
2016
- “It Was Easy”: A qualitative Analysis of Participants’ Experience Responding to Short Messages Service (SMS) surveys on Pre-Exposure Prophylaxis (PrEP) Adherence and sexual Behavior in East Africa.
2016
- Prevention-Effective Adherence per Short Message Service (SMS) within a demonstration Project of Pre-Exposure Prophylaxis (PrEP) Among HIV-Serodiscordant Couples In East Africa
2016
- Prevention-Effective Adherence In Demonstration Project of Pre-exposure Prophylaxis (PrEP) Among HIV SerodiscordantCouples In East Africa.
2016
- Describing point of entry into care and lost to program in a cohort of HIV positive pregnant women in a large urban center in Uganda
2016
- High rates of loss to follow-up among women on option B+ program attending care in urban Uganda
2016
- PK of FTC, TFV and 3TC in Ugandan and Nigerian Breastfeeding Mother-Infant Pairs
2016
- Transcriptomic Signature of Atorvastatin Response Among ART-Treated Adult In Africa
2016
- Atorvastatin Reduced T-Cell Activation and Exhaustion among Suboptimal Immune Responders: A Randomized Crossover Placebo Controlled Trial
2016
- Pre-ART Cryptococcal Antigen Titer is Associated with Failure of Preemptive Fluconazole Therapy.
2016
- Neurocognitive Function in HIV-Infected Persons With Cryptococcal Antigenemia.
2016
- Immunologic Discrimination of Cryptococcal IRIS from Culture-Positive Relapse
2016
- Pre-ART Cryptococcal Antigen Titer Associated With Preemptive Fluconazole Failure
2016
- Increase in CD4 Counts at Presentation to ART Care Among Urban HIV Clinics in Uganda
2016
- Comparative Efficacy of six Aspergillus-specific IgG Assays for the Diagnosis of Allergic Bronchopulmonary Aspergillosis(ABPA)
2016
- Exploring Attitudes And Perceptions Of Patients And Staff Towards A Fee For Service “After Hours” Clinic Supplementing Free Hiv Services In Uganda: A Qualitative Study
2015
- Long Term Virological Outcomes Of Hiv Infected Patients On Antiretroviral Treatment In Uganda
2015
- Monitorinbgd Of cyptoccosis Results to IUmprove Qua;ity pf Patients Care In a large Urban Clinic In Uganda
2015
- The 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which will be held from 25 – 28 April 2015 in Copenhagen, Denmark
2015
- Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda
2015
- Safety and Tolerability of a fixed dose combination tablet containing tenofovir disoproxil fumarate, emtricitabine plus rilpivirine in HIV-1 infected Ugandans
2015
- Immune Reconstitution and Viralogic Response Amongst Malnourished And Well Nourished Antiretroviral Experienced Children In Uganda.
2015
- Outcomes of HIV-infected individuals after ten years on antiretroviral therapy
2015
- Clinical decision and outcomes of patients suspected of treatment failure and tested for HIV-viral load at the Infectious Diseases Institute (IDI), Kampala, Uganda
2015
- Renal Safety of Tenofovir and Amphotericin co-administration in Cryptococcosis
2015
- The 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which will be held from 25 – 28 April 2015 in Copenhagen, Denmark.
2015
- Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda
2015
- Lack of clinically significant interaction between the levonorgestrel implant and nevirapine-based antiretroviral therapy.
2015
- Correlation between efavirenz and levonorgestrel plasma concentrations during a drug-drug interaction study.
2015
- Mortality After Diagnosis of Kaposi ’s sarcoma Among HIV-infected Adults in Sub-Saharan Africa: Overcoming High Losses to Follow-up to Derive More Accurate Inferences
2015
- Long term durability of fiRst line in a cohort of patients started on ART and followed up for 10 years in Uganda
2015
- Characteristics and outcomes of patients assessing HIV care and treatment through different modality of entry in a large urban clinic in Uganda.
2015
- Neurocgnitive Function In Africans Failing First Line ART & Responses to Second Line
2015
- Second-Line Treatment In Sub-Saharan Africa; Week 144 Follow – up of the EARNEST Trial.
2015
- Levonorgestrel Implant + EFV-Based ART: Unintended Pregnancies and Associated PK Data
2015
- Prognostic Model for Patients with Kaposi Sarcoma Treated With ART Alone In Africa
2015
- Cerebrospinal Fluid Cytokines and HIV-Associated Neurocognitive Disorders In Uganda.
2015
- Impact Of NRTI Cross-Resistance on Second Line PI + NRTI Therapy Outcomes In Africa
2015
- Atorvastatin Reduced T-Cell Activation and exhaustion Among sub-optimal Immune Responders: A Randomized Crossover Placebo Controlled Trial
2015
- Increases In CD4 Counts at Presentation of Care During the ART Era Among Urban HIV Clinic In Kampala Uganda
2015
- Hepatitis B vaccine response in Pediatric patients attending Rwanda Military Hospital
2015
- High Mobility Group Box(HMGB1) and HIV-Associated Kaposi Sarcoma In Africa
2015
- Facility-Level Factors Influeincing Retention In HIV Care In East Africa.
2015
- Monitoring and Switching of First-line ART in sub-Saharan Africa.
2015
- Detrimental Outcomes Of unmasking Cryptococcal Meningitis with Recent ART Initiation
2015
- Adjunctive Sertraline for the treatment of HIV-Associated Cryptococcal Meningitis
2015
- Delta-like 1 protein, vitamin D binding protein, and fetuin measurement in cerebrospinal fluid for detection of Mycobacterium tuberculosis meningitis.
2015
- Interleukin-6, Tumor Necrosis Factor-α Expression and Monocyte Subset Phenotype are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome
2015
- Characteristics and outcomes of patients seeking care at a new “co-pay” convenience clinic established to explore sustainable funding models in Uganda
2015
- Gene Xpert MTB/Rif for use in detection of meningitis due to Mycobacterium tuberculosis: a prospective trial
2015
- Delta-like 1 ligand (DLL1), vitamin D binding protein (VDBP), and fetuin in cerebrospinal fluid for detection of Mycobacterium tuberculosis meningitis
2015
- Ten Years Outcomes In A Cohort Of Patients Started On Antiretroviral Treatment In An Urban Clinic In Sub-Saharan Africa
2014
- Monitoring Antiretroviral Therapy In Uganda: Budget Impact Analysis Of Two Strategies For Viral Load Monitoring Versus Immunologic Monitoring. PIN 22
2014
- Diagnostic Performance of a Multiplex PCR Assay for Meningitis In an HIV-Infected Population In Uganda
2014
- Detection of High CSF Level of (1-3) – Beta-D-glucan In Cryptococcal Meningitis
2014
- Boosted Lopinavir vs boosted Atazanavir in patients failing an NNRTI first line regimen in an urban clinic in Kampala
2014
- The Cost-Effectiveness Of Antenatal Syphilis Screening Using Point-Of-Care Testing In Low And Middle Income Countries In Asia.
2014
- The Cost-Effectiveness Of Antenatal Syphilis Screening Using Point-Of-Care Testing In Latin America
2014
- Cost Of Patient Care At Different Stages Of Treatment Within The Public Health Model Of Hiv Care; Analysis From An Urban Hiv Centre In Uganda
2014
- Engaging traditional health practitioners in the early detection of Kaposi’s sarcoma in Uganda
2014
- Delayed Diagnosis of HIV-Associated Kaposi sarcoma in Uganda: A Qualitative Analysis
2014
- Low olevel of Kaposis Sarcoma Specific Knowledge & Screening Practices among clinicians in Uganda
2014
- Task-shifting & skin punch for the histologic Diagnosis of Kaposi’s sarcoma: A public Health Solution to a public Health problem.
2014
- . Effect of food on the steady-state pharmacokinetics of rilpivirine when administered as a fixed-dose combination in HIV-1 infected Ugandan adults
2014
- Non-invasive Assessment of Intracranial Pressure in Cryptococcal Meningitis using Tonometry or Ocular Ultrasound
2014
- Detection of High CSF Levels of (1→3)-Beta-D-glucan in Cryptococcal Meningitis
2014
- Effect of Adjunctive Sertraline on QTc Interval in Patients with Cryptococcal Meningitis
2014
- Impact of Antiretroviral Therapy on Kaposi’s Sarcoma Incidence Among HIV-Infected Adults in East Africa
2014
- Loss to program in pre-antiretroviral treatment care in a large urban clinic in Uganda 2.
2014
- Serum Biomarkers Following Induction Therapy for Cryptococcal Meningitis Predict Survival
2014
- Cost-savings of viral load testing before ART second line switch in a resource limited setting.
2014
- The role of Treatment Buddies in Mediating the Relationship between HIV Treatment Adherence, Mortality and time to first switch of ART
2013
- The Impact of Antiretroviral therapy on Kaposi Sarcoma incidence among HIV infected adults in East Africa.
2013
- The Effect of Therapeutic Lumbar Punctures on Acute Mortality from Cryptococcal Meningitis
- Engaging Traditional Health Practitioners in the Early Detection of Kaposi’s Sarcoma in Uganda
2013
- Antiretrovirals for Kaposi’s Sarcoma (ARKS): A randomized trial of protease inhibitor-based antiretroviral therapy for AIDS-associated Kaposi’s sarcoma in sub-Saharan Africa.
2013
- Low Level of Kaposi’s Sarcoma-Specific Knowledge and Screening Practices among Clinicians in Uganda.
2013
- Denning. Estimated burden of fungal disease in Uganda.
2013
- Determinants of Utilization of a No-Cost HIV Transition Clinic: A Cross Sectional Study of Young Adults Living with HIV/AIDS in Uganda.
2013
- Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
2013
- Sexual and Reproductive Health In HIV-positive young women in an Urban Clinic in Uganda; Causes of Vaginal discharge.
2013
- A study of the potential benefit of integration of quality sexual and reproductive health (SRH) with HIV care using a “stepped wedge” design
2013
- Sexual and reproductive health in young people with HIV in an urban clinic in Uganda: the important role of syphilis
2013
- Mycobacteremia and Associated Mortality among HIV-infected smear negative Tuberculosis Suspects in Uganda
2013
- Early Antiretroviral Therapy after Cryptococcal Meningitis is associated with Worse 26-week Survival.
2013
- HIV-pathogen interaction and the Immune Reconstitution Inflammatory Syndrome
2012
- Cost-effectiveness of HIV prevention strategies in Uganda
2012
- Constitutional symptoms and HIV severity influence clinicians’ decision to treat tuberculosis in sputum smear negative HIV-infected tuberculosis suspects in Uganda
2012
- Merry Efavirenz and nevirapine significantly affect artemether-lumefantrine pharmacokinetic exposure in HIV-Infected Ugandan adults
2012
- Diagnosing Kaposi Sarcoma(KS) in East Africa: How accurate are clinicians and Pathologists?
2012
- Baseline Mapping Survey of decentralised ART Service Provision in Uganda
2012
- HIV Viremia copy-years independently predict mortality in HIV-infected patients initiated on antiretroviral therapy in a resource-limited setting.
2012
- Implementation and results of real time provider entry electronic medical records in a large HIV program in Sub-Saharan Africa.
2012
- CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre
2012
- Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
2012
- Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in Uganda.
2011
- Cost-Effectiveness of Earlier Initiation of First Line Combination Antiretroviral Therapy in an Urban Outpatient HIV Clinic in Uganda.
2011
- Cost-Effectiveness of Rifampicin-Based Continuation Phase of Tuberculosis Treatment in Uganda
2011
- Cost-Effectiveness of the New Guidelines for the Prevention of Mother to Child Transmission of HIV in Uganda. Value in Health – November 2011 (Vol. 14, Issue 7, Page A275, DOI: 10.1016/j.jval.2011.08.243
2011
- Oral presentation on ‘T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort’
2011
- Steady-state exposure of ritonavir is reduced by a high fat meal in Ugandan patients receiving lopinavir plus ritonavir co-formulated tablets.
2011
- Unfavorable Pharmacokinetic Interaction between Artemether/lumefantrine and Rifampin-Based Tuberculosis Treatment.
2011
- Integration of HIV and TB services results in earlier and more prioritised ART initiation in Uganda
2011
- The uptake of antenatal syphilis screening and prevalence of syphilis among HIV- infected pregnant women at the Infectious Diseases Institute- Uganda
2011
- High-risk Sexual Behavior Persist among Young PLHIV Despite Heightened HIV Prevention Awareness at an Urban HIV Clinic in Uganda
2011
- Low HIV sero-conversion rates among HIV discordant couples attending a large urban HIV clinic in Uganda.
2011
- Minimal food effect on steady-state pharmacokinetics of lopinavir when administered as a tablet formulation in Ugandan HIV- positive patients.
2011
- Factors determining contraceptive use among HIV-infected women attending HIV/AIDS care in an urban center
2011
- Demographic data and treatment outcomes of HIV positive patients on ART aged 50 and above at the Adult Infectious Diseases Clinic, Kampala.
2011
- Patients with sustained viral suppression after 2 years on ART experience long term progressive immune reconstitution regardless of the CD4+ count at antiretroviral treatment star.
2011
- TUPE472 titled “Evaluation of the impact of TB-HIV integrated care in reducing the proportion of patients defaulting anti TB treatment in a large urban HIV clinic in Kampala, Uganda”
2011
- Reason for changing antiretroviral treatment before and after implementation of the 2006 WHO guidelines.
2011
- Trends and frequency of CD4+ cell count among patients on ART in a large HIV observational database in resource limited settings
2011
- Patients with sustained viral suppression after 2 years on ART experience long term progressive immune reconstitution regardless of the CD4+ count at antiretroviral treatment start.
2011
- Special Issues concerning HIV Infected Adolescents and Young People, National ART Sub Committee for the Uganda Integrated Guidelines for HIV Care in Adults, Adolescents and Children,31st March 2011,Kampala,Uganda
2011
- The HIV positive Male Adolescent,2nd Adolescent Health Workshop, A collaboration between Makerere University and Columbia University, March 22-23, 2011,Kampla,Uganda
2010
- High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort
2011
- CD4+ T-cell Recovery after ART in HIV-TB Co-infected Patients is Blunted in Patients with ART-associated TB Compared to Patients with TB Treated Prior to ART
2011
- Overview of clinical pharmacology research at the IDI
2010
- Accuracy of an ‘In-house’ sputum polymerase chain reaction assay for rapid diagnosis of sputum smear negative pulmonary TB at Mulago hospital, Uganda.
2010
- Multi-media educational tool (speaking book) increases knowledge of clinical trials among HIV-positive patients in Kampala, Uganda
2010
- Alcohol use, hepatotoxicity and liver disease in an ART program in Southwestern Uganda
2010
- Patients on ART in resource limited settings with episodes of intermediate viremia (1,001-10,000 copies/ml) are at risk of impaired immune-reconstitution and treatment failure
2010
- Perspectives in transition,” Knowledge, attitudes and practices of young people regarding HIV positive prevention in an urban HIV clinic in Uganda: A mixed methods study
2010
- HIV patients on antiretroviral treatment diagnosed with smear positive tuberculosis and smear negative/extra-pulmonary have similar mortality rates.
2010
- Pregnancy Intention and Pregnancy Risk Behavior Among Women Receiving HIV/AIDS Care in Uganda
2010
- Progressive normalization of liver enzyme elevation during the first 30 months of ART in an HIV positive patient cohort in Uganda.
2010
- Integrating Family Planning (FP) in HIV/AIDS Care Model: AIDC in Uganda
2010
- Sub-optimal nevirapine concentrations during intrapartum compared with postpartum in HIV-1 infected Ugandan women.
2010
- Medication refill adherence and viral rebound in a cohort of HIV-infected Ugandan adults in the 2nd year of antiretroviral therapy.
2010
- Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
2010
- Effect of the duration of antiretroviral therapy on the CD4 count at tuberculosis diagnosis in patients from a large urban clinic in Sub-Saharan Africa.
2010
- WHO Immunologic criteria are more predictive of treatment failure in patients from a Western Cohort compared to a cohort in Resource Limited Settings
2010
- Increased Baseline CD4-count at ART Initiation Improves Survival and Leads to Decreased Incidence of Tuberculosis in an Urban HIV Clinic in Sub-Saharan Africa.
2010
- MRNA Biomarkers of CD4 Immune Recovery with Antiretroviral Therapy in persons with AIDS in Sub-Saharan Africa.
2010
- Nevirapine plasma concentrations during initiation with 200 mg versus 400 mg daily in HIV/TB co-infected adults on rifampicin.
2010
- Sexual behavior of HIV-positive persons before and after one year of Antiretroviral therapy at the Infectious Diseases Clinic, Kampala, Uganda.
2010
- Sexual behavior of HIV-positive persons before and after one year of Antiretroviral therapy at the Infectious Diseases Clinic, Kampala, Uganda.
2009
- Examining drug default for treatment of tuberculosis in an urban HIV clinic in Uganda
2009
- Toxicity to fixed dose stavudine, lamivudine and nevirapine in Uganda is very high but not associated with increased virologic failure
2009
- Sexual behaviour of HIV infected patients on antiretroviral therapy (ART) in an urban HIV clinic in Kampala Uganda: a 3-year follow-up study.
2009
- Clinical and immunological outcomes of second line treatment delivered in a routine clinical setting in Uganda.
2009
- Barriers to ARV Therapy Adherence in a Cohort of Adolescents in Urban Uganda.
2009
- Very low rates of abacavir hypersensitivity reactions among African children in the ARROW (AntiRetroviral Research fOr Watoto) trial
2009
- Pharmacokinetics of Once versus Twice Daily Lamivudine and Abacavir in HIV-1 Infected Ugandan Children in the ARROW trial.
2009
- High rate of misclassification of treatment failure based on WHO immunological criteria in resource limited settings (Uganda)
2009
- The use of efavirenz is associated with a decreased incidence of tuberculosis after antiretroviral therapy initiation in an urban HIV clinic in sub-Saharan Africa
2009
- Sexually Transmitted Infections and family Planning usage among Young Adults accessing care at Infectious Diseases Institute (IDI), Mulago Kampala, Uganda
2009
- Sexually Transmitted Infection (STI) symptom prevalence, knowledge, disclosure and treatment seeking behaviours amongst discordant couples at the Infectious Diseases Institute
2009
- Reliability of Reporting of Recent Sexual Activity within Couples
2009
- Predictors of Pregnancy Among HIV-Positive Women attending an Urban HIV-Care Center
2009
- Cost effectiveness of Serum Cryptococcal antigen (CRAG) screening to Prevent Death in HIV- infected persons with CD4 <100/μL in sub-Saharan Africa. Oral
2009
- Stavudine toxicity is the main reason for treatment change in women in a prospective cohort of patients started on first line antiretroviral treatment (ART) in Uganda
2009
- Factors associated with increasing HIV-1 resistance to antiretroviral therapy in an urban cohort in Kampala, Uganda
2009
- Health Control Beliefs, Risk Behaviour and HIV-serostatus in Soweto, South Africa
2009
- Gene expression biomarkers in blood predict cryptococcal immune reconstitution inflammatory syndrome
2009
- Low incidence of liver enzyme elevation in HIV infected patients attending a large Urban treatment Center in Kampala, Uganda
2009
- Reasons for treatment change in a 3 year prospective cohort of patients started on first line antiretroviral treatment in Uganda
2009
- More advanced disease at ART initiation and high death rate from OIs explain higher mortality among African patients initiating antiretroviral therapy (ART) in Uganda compared to London
2009
- Serum Inflammatory Biomarkers Predict HIV Immune Reconstitution Inflammatory Syndrome and Death after Cryptococcal Meningitis
2009
- Reconstitution Inflammatory Syndrome (KS-IRIS) In Africa: Initial Findings From A Prospective Evaluation (oral presentation)
2009
- Risk Factors for Severe Anemia after Initiation of ART in Urban Uganda
2009
- Determinants of contraceptive use among HIV infected women attend care in an urban center
2009
- Sexually Transmitted Infection (STI) frequency and challenges of using family planning among discordant couples at AIDC
2009
- Initiating Antiretroviral Therapy at CD4 Counts Below 350 cells/ µl. What Does This Mean To HIV/AIDS Care Programs In Uganda?
2009
- Integrating Tuberculosis (TB) Screening and HIV/AIDS Care Improves Diagnosis of TB-HIV Co-infections At An Urban Public HIV Clinic In Uganda
2009
- Factors associated with pregnancy intentions among women receiving HIV/AIDS Care in Uganda
2009
- Traditional medicine use in the context of antiretroviral therapy in Uganda.
2009
- Sharing experiences and optimizing south-to-south collaboration in preparing resource limited sites for vaccine trials: The TB Vaccine sites.
2009
- Clinical pharmacology for Global Health, a North – South – South partnership
2009
- Irish post-graduate training supports a multi-disciplinary health team in Africa to confront HIV/AIDS, tuberculosis and malaria
2008
- The Workforce and Cost Implications of Substituting Nurses and Pharmacists for Doctors in the Follow-up of Patients with AIDS on Antiretroviral Therapy in Uganda
2008
- Clinical presentation of epidemic kaposi’s sarcoma differs by gender in kampala, Uganda
2008
- Clinical manifestations and cytokine profiles in HIV-infected Ugandan patients who develop immune reconstitution inflammatory syndrome (IRIS)
2008
- On-going sexual transmission of HBV infection among the highly susceptible adult population of Rakai, Uganda.
2008
- Hepatitis C seroprevance among HIV positive and HIV-negative patients in Kampala, Uganda.
2008
- Patterns and predictors of suboptimal CD4 reconstitution among patients with viral suppression in an urban cohort initiating antiretroviral therapy in sub-Saharan Africa.
2008
- Removing the obstacles towards timely diagnosis of kaposi’s sarcoma in sub-saharan africa: use of simple equipment and easier patient access to hasten the performance of biopsies.
2008
- Severe sepsis in two Ugandan hospitals: a prospective study evaluating the management and outcomes of a predominantly HIV-1 infected population.
2008
- Microarray-based analysis of immune activation in AIDS patients in Sub-Saharan Africa before and after initiation of antiretroviral therapy.
2008
- Clinical presentation of epidemic Kaposi’s Sarcoma differs by gender in Kampala, Uganda
2008
- Clinical significance of sub-optimal CD4 reconstitution despite viral suppression in an urban cohort initiating antiretroviral therapy in sub-Saharan Africa.
2008
- Steady-state pharmacokinetic comparison of generic and branded formulations of nevirapine, stavudine (d4T), and lamivudine (3TC) in HIV-infected Ugandan adults. Journal of Antimicrobial Chemotherapy
2008
- Clinical significance of sub-optimal CD4 reconstitution despite viral suppression in an urban cohort initiating antiretroviral therapy in sub-Saharan Africa
2008
- High rates of opportunistic infections (OIs) and mortality during first two years of ART in Uganda compared to African patients in London
2008
- The Cost-Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Kampala, Uganda
2008
- Validation of the quality of data collection in a large observational clinic database in Uganda using a nested research cohort.
2008
- Hepatitis B infection in Special populations
2008
- HIV subtype D is associated with a higher risk for dementia than subtype A in sub-Saharan Africa.
2008
- Biomarkers of Immune Activation Are Predictors of HIV Immune Reconstitution Inflammatory Syndrome
2008
- Lactate measurement of patients with suspected lactic acidosis with a hand-held analyzer in a large outpatient HIV clinic in Kampala, Uganda
2008
- Losses to follow-up in a large ART programme in Uganda
2008
- Cause-specific mortality and contribution of Immune Reconstitution Inflammatory Syndrome (IRIS) during first two years of ART in Uganda
2008
- Spectrum of liver diseases in HIV infected patients in East Africa
2007
- Sexual Behavior of Persons on Antiretroviral Therapy With Improved Quality of Life
2007
- Immune Reconstitution Inflammatory Syndrome and Post-Antiretroviral Tuberculosis among HIV-infected Ugandan Children.
2007
- Can response of Pruritic Papular Eruption (PPE) to highly active antiretroviral therapy (HAART) be used as a clinical parameter to predict virological outcome?
2007
- Factors associated with a reduced CD4+ count response to highly active antiretroviral treatment in Sub-Saharan Africa
2007
- Outcomes of Cryptococcal Meningitis in Sub-Saharan Africa in the Era of Antiretroviral Therapy (ART) Availability
2007
- Immune Reconstitution Inflammatory Syndrome in HIV Infected Ugandans
2007
- Use of Microarrays to Assess Immune Activation in HIV Immune Reconstitution Inflammatory Syndrome
2007
- A need to integrate family planning services (FP) in HIV/AIDS care package for HIV positive women: a study at Infectious Diseases Institute (IDI)
2007
- Impact of an antiretroviral (ART) pharmacy refill program (PRP) in a resource constrained setting: experience at the infectious diseases institute (IDI) Uganda
2007
- Health Seeking Behavior for Sexually Transmitted Infections (STIs) amongst HIV Positive Female Patients and their spouses. Adult Infectious Diseases Clinic (AIDC) in Uganda
2007
- Factors affecting condom use among HIV/AIDS women at a large urban HIV clinic in Kampala, Uganda
2007
- Reinforcement of TB screening identifies a high burden of pulmonary tuberculosis among HIV/AIDS patients in the Mulago Immune Suppression Clinic, Uganda
2007
- High incidence of new opportunistic infections after starting antiretroviral treatment in Kampala, Uganda
2007
- High incidence of symptomatic hyperlactemia in patients receiving stavudine: a case series from a resource limited setting, Uganda
2007
- Assessing sexual risk reduction needs of adolescents living with HIV in a clinical care setting
2007
- Neurocognitive improvement with antiretroviral therapy among HIV positive individuals at the infectious diseases institute
2007
- The evolution of patient knowledge on the cause and transmission of HIV after one year of HAART
2007
- The impact of malnutrition on survival and immunological response in HIV infected patients starting antiretroviral therapy in Uganda
2007
- Failure of clinical and immunologic criteria to identify virologic failure in a resource limited setting (RLS): The Infectious Diseases Institute (IDI) Uganda experience
2007
- 18 months follow up of second line lopinavir/ritonavir (LPV/r) containing therapy after failing first line non nucleoside reverse transcriptase inhibitor (NNRTI) containing regimens in a resource limited setting (RLS): a Ugandan experience
2007
- Antiretroviral Therapy in an Urban African Cohort does not prevent significant early mortality
2007
- Immune Reconstitution Inflammatory Syndrome in HIV Infected Ugandans
2007
- Can response of Pruritic Papular Eruption (PPE) to highly active antiretroviral therapy (HAART) be used as a clinical parameter to predict virological outcome?
2007
- Predictors of long-term viral failure among Ugandan children and adults treated with ART and monitored using clinical and immunologic criteria
2007
- Evaluation of clinical and laboratory parameters to predict viral response to Antiretroviral Therapy in Uganda
2007
- Mean Corpuscular Volume (MCV) and Adherence to Antiretroviral Therapy in Sub-Saharan Africa
2006
- Filter Paper Transfer of Whole Blood Spot Specimens may be Reliable for Virological Monitoring of Africans on Antitretroviral Therapy
2006
- Effects of antiretroviral therapy on bone age in perinatally-infected HIV-positive adolescents in sub-Saharan Africa
2006
- Very low CD4 T cell counts and low total lymphocyte counts at initiation of HAART are associated with a poor outcome in the first 6 months of antiretroviral treatment
2006
- Cryptoccocal Meningitis a common cause of mortality among AIDS patients initiated on HAART
2006
- Viral load monitoring is critical to assess early paediatric response to highly active antiretroviral therapy in a resource limited setting: The Ugandan experience
2006
- Unmasking of mycobacteria tuberculosis in patients initiating free ARVs in an urban HIV clinic in Kampala Uganda
2006
- The early unmasking (within 30 days) of Tuberculosis (TB) in HIV infected Ugandans starting antiretroviral therapy (ART) – a review of 16 cases
2006
- Response of Pruritic Papular Eruption (PPE) to highly active antiretroviral therapy (HAART) may represent a clinical marker of virological outcome.
2006
- : CD38 Expression on CD8 T cells with or without other markers (HLA DR and CD45RA) is not adequate to predict the virological response to antiretroviral therapy (ART) in Ugandans.
2006
- Nucleoside-associated lactic acidosis in HIV-1 infected African patients
2006
- Comparison of two manual bead-based assays (Dyanbeads and Cytospheres) to FACS count at a public, urban clinic in Kampala, Uganda
2006
- The Dual Importance of Immunologic and Virologic Monitoring of Antiretroviral Therapy in Resource-limited Settings
2006
- A prospective study of HIV-infected adolescents: monitoring growth, development and recovery while on antiretroviral therapy
2006
- Second line lopinavir/ritonavir containing therapy is effective without major side effects after failing first line NNRTI containing regimens: 12 months follow up study at Mulago Hospital Adult Infectious Diseases Clinic (AIDC)
2006
- Trimethoprim-Sulfamethoxazole prophylaxis in HIV and malaria co-infection in Kampala
2006
- Divine healing as a factor for non adherence to HAART at the Infectious Diseases Institute, Kampala, Uganda
2006
- Early Success of Antiretroviral Therapy in a sub-Saharan African Cohort
2006
- Successful ARV Roll-out : Nurse practitioner
2006
- Empowering nurses in Africa in management of patients on antiretroviral therapy. Infectious Diseases Institute experience, Kampala, Uganda
2006
- The evolution of patient knowledge on the cause and transmission of HIV after one year of highly active anti-retroviral therapy (HAART)
2005
- Rapid Decline In CD8 T Cell Activation In HIV Infected Ugandans Taking Antiretroviral Therapy Towards That of Healthy Europeans
2005
- Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4 positive lymphocyte counts in Maryland, USA and Kampala, Uganda
2005
- Routine Cryptococcal Antigen(CRAG) Screening in AIDS Patients on HAART at the Infectious Diseases Institute, Kampala, Uganda
2005
- Assessment of clinical training at the Infectious Disease Institute
2005
- Counseling model for initiation of antiretroviral therapy: The Infectious Diseases Institute Model
2005
- Reasons for switching therapy for patients not failing first line antiretroviral therapy in the infectious diseases institute –Kampala
2005
- Evaluation of heat denatured HIV-1 p24 antigen as an inexpensive marker for HIV-1 viral load in non-B Subtypes in Kampala, Uganda
2005
- A study of clinical presentation and aetiologies of headache among HIV seropositive patients of the infectious diseases clinic- the basis for developing a resource constrained clinical algorithm
2005
- “Access to Highly Active Anti Retroviral Therapy (HAART) in Uganda: Experiences and challenges at the Adult Infectious Diseases Clinic (IDC), Mulago Hospital, Kampala, Uganda
2005
- Treatment Outcomes for Antiretroviral Therapy in Uganda
2004
- Improvement of Psoriatic lesions after starting Chloroquine in 3 African HIV positive patients
2004
- Health beliefs and behaviors of HIV infected people treated with antiretroviral therapy in a resource-limited setting of Kampala, Uganda
2004
- Total lymphocyte count of 1200 cells/mm3 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda
2004
- Treatment Outcomes at the Mulago Hospital AIDS in Kampala, Uganda: A Resource-Limited Setting
2004
- Training Medical Officers in Africa towards capacity building for provision of expanded Anti retroviral treatment
2004
- Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda
2003
